drugset / Trial / NCT01442766
Donepezil Trial for Motor Recovery in Acute Stroke
RandomizedParallel-groupQuadruple-blindTreatment
Summary
AIMS: To establish: 1) whether motor deficits in acute stroke improve more in patients taking donepezil, relative to placebo, for 12 weeks; 2) whether brain functional MRI changes as a result of donepezil after 12 weeks.
Timeline
- Start
- 2011-11
- Primary completion
- 2013-11
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donepezil | Small molecule | 10 mg | — |